ASCO Annual Meeting ASCO Meeting Previews AUA Meeting AUA Meeting: Prostate Cancer AUA Meeting Previews ASCO GU Recaps Innovation Celebration: Videos Innovation Celebration: Articles Urology Times Journal UroView Virtual Tumor Board Risk Factors of Cardiovascular Disease and Management of Prostate Cancer

ASCO Annual Meeting ASCO Meeting PreviewsAUA MeetingAUA Meeting: Prostate CancerAUA Meeting PreviewsASCO GU Recaps Innovation Celebration: VideosInnovation Celebration: ArticlesUrology Times JournalUroViewVirtual Tumor BoardRisk Factors of Cardiovascular Disease and Management of Prostate Cancer

View More Prostate Cancer Bladder Cancer Kidney Cancer BPH Next-Generation Imaging Genomic Testing Kidney Stones OAB and Incontinence Sexual Dysfunction Hormone Therapy

Prostate CancerBladder CancerKidney CancerBPHNext-Generation ImagingGenomic TestingKidney StonesOAB and IncontinenceSexual DysfunctionHormone Therapy

View More Health Law & Policy Malpractice Consult Practice Management

Health Law & PolicyMalpractice ConsultPractice Management

All Clinical Benign Conditions Bladder Cancer BPH Female Urology Genitourinary Cancers Hormone Therapy Kidney Cancer Kidney Stones Men's Health Next-Generation Imaging Pediatrics Prostate Cancer Sexual Dysfunction Urologic Surgery

All ClinicalBenign ConditionsBladder CancerBPHFemale UrologyGenitourinary CancersHormone TherapyKidney CancerKidney StonesMen's HealthNext-Generation ImagingPediatricsProstate CancerSexual DysfunctionUrologic Surgery

Podcasts 'Y'tube UroView UTv Videos Around the Practice BPH Videos Case-Based Peer Perspectives Medical World News Rapid Readouts Urology Medical Perspectives Viewpoints Virtual Tumor Board

Podcasts'Y'tubeUroViewUTv VideosAround the PracticeBPH VideosCase-Based Peer PerspectivesMedical World NewsRapid ReadoutsUrology Medical PerspectivesViewpointsVirtual Tumor Board

Conference Listing Conference Previews Conference Recaps

Conference ListingConference Previews Conference Recaps

Editorial Advisory Board Supplements and Featured Publications Urologists in Cancer Care Urology Times Journal

Editorial Advisory BoardSupplements and Featured PublicationsUrologists in Cancer CareUrology Times Journal

Live Events Virtual Events

Interactive Tools Job Board Partners Sponsored

Interactive ToolsJob BoardPartnersSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

About Us
Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

© 2022 MJH Life Sciences and Urology Times. All rights reserved.

Spotlight

ASCO Annual Meeting
ASCO Meeting Previews
AUA Meeting
AUA Meeting: Prostate Cancer
AUA Meeting Previews
ASCO GU Recaps
Innovation Celebration: Videos
Innovation Celebration: Articles
Urology Times Journal
UroView
Virtual Tumor Board
Risk Factors of Cardiovascular Disease and Management of Prostate Cancer

ClinicalSee All >

Prostate Cancer
Bladder Cancer
Kidney Cancer
BPH
Next-Generation Imaging
Genomic Testing
Kidney Stones
OAB and Incontinence
Sexual Dysfunction
Hormone Therapy

BusinessSee All >

Health Law & Policy
Malpractice Consult
Practice Management

About Us
Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

© 2022 MJH Life Sciences^™ and Urology Times. All rights reserved.

New Products & Services

January 1, 2004

Waltham, MA-Praecis Pharmaceuticals has received FDA approval to market abarelix (Plenaxis) for men with advanced prostate cancer.

Related Content:

Oral testosterone undecanoate shows promising results for first use in the real world

Oral testosterone undecanoate shows promising results for first use in the real world

Pivotal data for lumasiran in PH1 published in NEJM

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Nedosiran explored in primary hyperoxaluria type 3